Cite
Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.
MLA
Harding-Esch, Emma M., et al. “Antimicrobial Resistance Point-of-Care Testing for Gonorrhoea Treatment Regimens: Cost-Effectiveness and Impact on Ceftriaxone Use of Five Hypothetical Strategies Compared with Standard Care in England Sexual Health Clinics.” Eurosurveillance (15607917), vol. 25, no. 43, Oct. 2020, pp. 1–12. EBSCOhost, https://doi.org/10.2807/1560-7917.ES.2020.25.43.1900402.
APA
Harding-Esch, E. M., Huntington, S. E., Harvey, M. J., Weston, G., Broad, C. E., Adams, E. J., & Sadiq, S. T. (2020). Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics. Eurosurveillance (15607917), 25(43), 1–12. https://doi.org/10.2807/1560-7917.ES.2020.25.43.1900402
Chicago
Harding-Esch, Emma M., Susie E. Huntington, Michael J. Harvey, Georgie Weston, Claire E. Broad, Elisabeth J. Adams, and S. Tariq Sadiq. 2020. “Antimicrobial Resistance Point-of-Care Testing for Gonorrhoea Treatment Regimens: Cost-Effectiveness and Impact on Ceftriaxone Use of Five Hypothetical Strategies Compared with Standard Care in England Sexual Health Clinics.” Eurosurveillance (15607917) 25 (43): 1–12. doi:10.2807/1560-7917.ES.2020.25.43.1900402.